rs61754130

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001003800.2(BICD2):​c.269A>G​(p.Lys90Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00553 in 1,614,180 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0043 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0057 ( 32 hom. )

Consequence

BICD2
NM_001003800.2 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:9

Conservation

PhyloP100: 1.66

Publications

9 publications found
Variant links:
Genes affected
BICD2 (HGNC:17208): (BICD cargo adaptor 2) This gene is one of two human homologs of Drosophila bicaudal-D and a member of the Bicoid family. It has been implicated in dynein-mediated, minus end-directed motility along microtubules. It has also been reported to be a phosphorylation target of NIMA related kinase 8. Two alternative splice variants have been described. [provided by RefSeq, Jul 2008]
BICD2 Gene-Disease associations (from GenCC):
  • autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009992003).
BP6
Variant 9-92729208-T-C is Benign according to our data. Variant chr9-92729208-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 235235.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00434 (661/152340) while in subpopulation NFE AF = 0.0072 (490/68034). AF 95% confidence interval is 0.00668. There are 3 homozygotes in GnomAd4. There are 322 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 661 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BICD2NM_001003800.2 linkc.269A>G p.Lys90Arg missense_variant Exon 2 of 7 ENST00000356884.11 NP_001003800.1 Q8TD16-2Q96FU2
BICD2NM_015250.4 linkc.269A>G p.Lys90Arg missense_variant Exon 2 of 8 NP_056065.1 Q8TD16-1Q96FU2
BICD2XM_017014551.2 linkc.350A>G p.Lys117Arg missense_variant Exon 2 of 8 XP_016870040.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BICD2ENST00000356884.11 linkc.269A>G p.Lys90Arg missense_variant Exon 2 of 7 1 NM_001003800.2 ENSP00000349351.6 Q8TD16-2
BICD2ENST00000375512.3 linkc.269A>G p.Lys90Arg missense_variant Exon 2 of 8 1 ENSP00000364662.3 Q8TD16-1

Frequencies

GnomAD3 genomes
AF:
0.00435
AC:
662
AN:
152222
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00111
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.000981
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00414
Gnomad FIN
AF:
0.00744
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00720
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00459
AC:
1151
AN:
251024
AF XY:
0.00480
show subpopulations
Gnomad AFR exome
AF:
0.000862
Gnomad AMR exome
AF:
0.00142
Gnomad ASJ exome
AF:
0.000696
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00711
Gnomad NFE exome
AF:
0.00703
Gnomad OTH exome
AF:
0.00359
GnomAD4 exome
AF:
0.00566
AC:
8269
AN:
1461840
Hom.:
32
Cov.:
32
AF XY:
0.00565
AC XY:
4106
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.000538
AC:
18
AN:
33480
American (AMR)
AF:
0.00148
AC:
66
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000842
AC:
22
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00387
AC:
334
AN:
86258
European-Finnish (FIN)
AF:
0.00860
AC:
459
AN:
53372
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5768
European-Non Finnish (NFE)
AF:
0.00641
AC:
7124
AN:
1112008
Other (OTH)
AF:
0.00394
AC:
238
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
501
1002
1503
2004
2505
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
246
492
738
984
1230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00434
AC:
661
AN:
152340
Hom.:
3
Cov.:
33
AF XY:
0.00432
AC XY:
322
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.00111
AC:
46
AN:
41574
American (AMR)
AF:
0.000980
AC:
15
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00414
AC:
20
AN:
4832
European-Finnish (FIN)
AF:
0.00744
AC:
79
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00720
AC:
490
AN:
68034
Other (OTH)
AF:
0.00379
AC:
8
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
39
77
116
154
193
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00602
Hom.:
9
Bravo
AF:
0.00369
TwinsUK
AF:
0.00405
AC:
15
ALSPAC
AF:
0.00597
AC:
23
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00581
AC:
50
ExAC
AF:
0.00470
AC:
571
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00513
EpiControl
AF:
0.00581

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
Sep 23, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23664116, 27549087) -

Mar 03, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BICD2: BS2 -

Oct 03, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Uncertain:1
Mar 07, 2017
Unit for Genetic & Epidemiological Research on Neurological Disorders, Instituto de Investigação e Inovação em Saúde
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

not specified Benign:1
Apr 21, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jun 18, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

BICD2-related disorder Benign:1
Aug 30, 2022
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Neuronopathy, distal hereditary motor, autosomal dominant Benign:1
-
Inherited Neuropathy Consortium
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
18
DANN
Benign
0.79
DEOGEN2
Benign
0.25
.;T
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.23
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.84
T;T
M_CAP
Benign
0.0078
T
MetaRNN
Benign
0.010
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.36
N;N
PhyloP100
1.7
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-0.52
N;N
REVEL
Benign
0.051
Sift
Benign
0.71
T;T
Sift4G
Benign
0.66
T;T
Polyphen
0.0010
B;B
Vest4
0.21
MVP
0.74
MPC
0.44
ClinPred
0.0066
T
GERP RS
4.1
Varity_R
0.072
gMVP
0.093
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61754130; hg19: chr9-95491490; COSMIC: COSV108874239; API